Abbott Laboratories (ABT) delivered a strong Q2 2026 performance that surprised Wall Street, with the healthcare giant posting a double beat on both top and bottom lines on July 16, 2026. The earnings ...
Hackers say they stole 30 million records, including one million Social Security numbers, from Abbott Laboratories. No ...
Freenome (FRNM) and Abbott Laboratories (ABT) said Monday that the US Food and Drug Administration approved SimpleScreen CRC, a blood-based colorectal cancer screening test. The c ...
Abbott Laboratories is investigating two separate cybersecurity incidents after confirming unauthorized access to internal ...
Abbott Laboratories (NYSE:ABT) at $90.53 is a Buy. The healthcare giant has been swept up in a sector-wide rotation out of defensive names, even as its diabetes franchise compounds and its medical ...
The healthcare company said its profit fell to $928 million, or 53 cents a share, in the second quarter, from $1.78 billion, ...
Abbott Laboratories (ABT) stock rises as the company reports better-than-expected Q2 2026 financials and boosts its full-year ...
Abbott Laboratories is one of the world's leading medical device makers. It routinely develops and markets newer products, and its portfolio boasts dozens of patented devices that generate consistent ...
Jensen Investment Management, an asset management company based in the US, released its second-quarter 2026 investor letter ...
Abbott Laboratories is now fairly valued after a 26% decline from its 2021 highs, but I maintain a Hold rating. ABT's Q1/26 saw 7.8% revenue growth, with medical devices leading, but operating income ...
Shares of Abbott Laboratories ABT -0.78% rallied 1.59% to $92.18 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX +0.28% falling ...
Abbott Laboratories (NYSE:ABT) is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...